These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ☑ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
| ☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
20-0709285
|
|
|
(State or other jurisdiction of Incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
|
5201 Interchange Way, Louisville, KY
|
40229
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
||
|
Non-accelerated filer
|
☑
|
(Do not check if a smaller reporting company)
|
Smaller reporting company
|
☐
|
|
|
Emerging growth company
|
☑
|
|
Page No.
|
||
|
PART I FINANCIAL INFORMATION
|
||
|
ITEM 1
|
Financial Statements (Unaudited)
|
|
|
3
|
||
|
4
|
||
|
5
|
||
|
6
|
||
|
7
|
||
|
ITEM 2
|
22
|
|
|
ITEM 3
|
33
|
|
|
ITEM 4
|
33
|
|
|
PART II OTHER INFORMATION
|
||
|
ITEM 1
|
34
|
|
|
ITEM 1A
|
34
|
|
|
ITEM 2
|
34
|
|
|
ITEM 3
|
34
|
|
|
ITEM 4
|
34
|
|
|
ITEM 5
|
34
|
|
|
ITEM 6
|
34
|
|
|
Signatures
|
35
|
|
|
36
|
||
|
PART
|
FINANCIAL INFORMATION
|
|
Item1.
|
Financial Statements
|
|
(unaudited)
|
||||||||
|
ASSETS
|
March 31,
2017
|
December 31,
2016
|
||||||
|
Current assets:
|
||||||||
|
Cash
|
$
|
2,248
|
$
|
2,865
|
||||
|
Accounts receivable, net of allowances of $63 in 2017 and $35 in 2016
|
3,982
|
2,181
|
||||||
|
Inventories
|
60,886
|
62,185
|
||||||
|
Other current assets
|
13,045
|
11,625
|
||||||
|
Total current assets
|
80,161
|
78,856
|
||||||
|
Property, plant and equipment, net
|
7,604
|
7,590
|
||||||
|
Deferred income taxes
|
8,809
|
6,288
|
||||||
|
Deferred financing costs, net
|
745
|
139
|
||||||
|
Goodwill
|
134,303
|
134,390
|
||||||
|
Other intangible assets, net
|
26,962
|
27,138
|
||||||
|
Master Settlement Agreement - escrow deposits
|
30,541
|
30,410
|
||||||
|
Other assets
|
182
|
209
|
||||||
|
Total assets
|
$
|
289,307
|
$
|
285,020
|
||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
$
|
7,556
|
$
|
9,153
|
||||
|
Accrued liabilities
|
10,361
|
15,336
|
||||||
|
Accrued interest expense
|
402
|
394
|
||||||
|
Current portion of long-term debt
|
5,850
|
1,650
|
||||||
|
Revolving credit facility
|
29,550
|
15,034
|
||||||
|
Total current liabilities
|
53,719
|
41,567
|
||||||
|
Notes payable and long-term debt
|
191,996
|
201,541
|
||||||
|
Postretirement benefits
|
4,439
|
4,407
|
||||||
|
Pension benefits
|
362
|
423
|
||||||
|
Other long-term liabilities
|
2,916
|
3,024
|
||||||
|
Total liabilities
|
253,432
|
250,962
|
||||||
|
Commitments and contingencies
|
||||||||
|
Stockholders' equity:
|
||||||||
|
Preferred stock; $0.01 par value; authorized shares 40,000,000; issued and outstanding shares -0-
|
-
|
-
|
||||||
|
Common stock, voting, $0.01 par value; authorized shares, 190,000,000; issued and outstanding shares, 2017 18,823,935 and 2016 18,402,022
|
188
|
184
|
||||||
|
Common stock, nonvoting, $0.01 par value; authorized shares, 10,000,000; issued and outstanding shares -0-
|
-
|
-
|
||||||
|
Additional paid-in capital
|
104,640
|
104,895
|
||||||
|
Accumulated other comprehensive loss
|
(3,858
|
)
|
(4,049
|
)
|
||||
|
Accumulated deficit
|
(65,095
|
)
|
(66,972
|
)
|
||||
|
Total stockholders' equity
|
35,875
|
34,058
|
||||||
|
Total liabilities and stockholders' equity
|
$
|
289,307
|
$
|
285,020
|
||||
|
Three Months Ended
|
||||||||
|
March 31,
2017
|
March 31,
2016
|
|||||||
|
Net sales
|
$
|
66,788
|
$
|
49,866
|
||||
|
Cost of sales
|
39,122
|
25,219
|
||||||
|
Gross profit
|
27,666
|
24,647
|
||||||
|
Selling, general and administrative expenses
|
16,909
|
13,738
|
||||||
|
Operating income
|
10,757
|
10,909
|
||||||
|
Interest expense
|
4,933
|
8,462
|
||||||
|
Investment income
|
(114
|
)
|
-
|
|||||
|
Loss on extinguishment of debt
|
6,116
|
-
|
||||||
|
Income (loss) before income taxes
|
(178
|
)
|
2,447
|
|||||
|
Income tax expense (benefit)
|
(2,055
|
)
|
213
|
|||||
|
Net income
|
$
|
1,877
|
$
|
2,234
|
||||
|
Basic earnings per common share:
|
||||||||
|
Net income
|
$
|
0.10
|
$
|
0.31
|
||||
|
Diluted earnings per common share:
|
||||||||
|
Net income
|
$
|
0.10
|
$
|
0.27
|
||||
|
Weighted average common shares outstanding:
|
||||||||
|
Basic
|
18,734,393
|
7,198,337
|
||||||
|
Diluted
|
19,633,353
|
8,354,659
|
||||||
|
Three Months Ended
|
||||||||
|
March 31,
2017
|
March 31,
2016
|
|||||||
|
Net income
|
$
|
1,877
|
$
|
2,234
|
||||
|
Other comprehensive income, net of tax -
|
||||||||
|
Pension and postretirement
|
||||||||
|
Amortization of unrealized losses recorded in cost of sales
|
6
|
6
|
||||||
|
Amortization of unrealized losses recorded in selling, general and administrative expenses
|
114
|
117
|
||||||
|
Unrealized gain on investments, net of tax of $43
|
71
|
-
|
||||||
|
191
|
123
|
|||||||
|
Comprehensive income
|
$
|
2,068
|
$
|
2,357
|
||||
|
Three Months Ended
|
||||||||
|
March 31,
2017
|
March 31,
2016
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income
|
$
|
1,877
|
$
|
2,234
|
||||
|
Adjustments to reconcile net income to net cash provided by (used) in operating activities:
|
||||||||
|
Loss on extinguishment of debt
|
6,116
|
-
|
||||||
|
Depreciation expense
|
354
|
293
|
||||||
|
Amortization of deferred financing costs
|
294
|
362
|
||||||
|
Amortization of original issue discount
|
66
|
259
|
||||||
|
Amortization of other intangible assets
|
175
|
-
|
||||||
|
Interest incurred but not paid on PIK toggle notes
|
-
|
2,254
|
||||||
|
Deferred income taxes
|
(2,564
|
)
|
41
|
|||||
|
Stock-based compensation expense
|
45
|
22
|
||||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Accounts receivable
|
(1,801
|
)
|
1,291
|
|||||
|
Inventories
|
1,299
|
(3,637
|
)
|
|||||
|
Other current assets
|
(1,420
|
)
|
1,455
|
|||||
|
Other assets
|
26
|
416
|
||||||
|
Accounts payable
|
(1,597
|
)
|
724
|
|||||
|
Accrued pension liabilities
|
60
|
64
|
||||||
|
Accrued postretirement liabilities
|
32
|
(28
|
)
|
|||||
|
Accrued liabilities and other
|
(5,302
|
)
|
(4,773
|
)
|
||||
|
Net cash provided by (used in) operating activities
|
(2,340
|
)
|
977
|
|||||
|
Cash flows from investing activities:
|
||||||||
|
Capital expenditures
|
(368
|
)
|
(454
|
)
|
||||
|
Net cash used in investing activities
|
(368
|
)
|
(454
|
)
|
||||
|
Cash flows from financing activities:
|
||||||||
|
Proceeds from 2017 revolving credit facility
|
29,550
|
-
|
||||||
|
Proceeds from 2017 first lien term loans
|
145,000
|
-
|
||||||
|
Proceeds from 2017 second lien term loan
|
55,000
|
-
|
||||||
|
Payments of financing costs
|
(4,792
|
)
|
-
|
|||||
|
Proceeds from (payments of) old revolving credit facility
|
(15,034
|
)
|
1,000
|
|||||
|
Payments of first lien term loan
|
(147,312
|
)
|
(3,150
|
)
|
||||
|
Payments of second lien term loan
|
(60,000
|
)
|
-
|
|||||
|
Prepaid equity issuance costs
|
-
|
(268
|
)
|
|||||
|
Exercise of options
|
679
|
-
|
||||||
|
Surrender of options
|
(1,000
|
)
|
-
|
|||||
|
Net cash provided by (used in) financing activities
|
2,091
|
(2,418
|
)
|
|||||
|
Net decrease in cash
|
(617
|
)
|
(1,895
|
)
|
||||
|
Cash, beginning of period
|
2,865
|
4,835
|
||||||
|
Cash, end of period
|
$
|
2,248
|
$
|
2,940
|
||||
|
Supplemental schedule of noncash financing activities:
|
||||||||
|
Accrued expenses incurred for financing costs
|
$
|
226
|
$
|
-
|
||||
|
Accrued expenses incurred for prepaid equity costs
|
$
|
-
|
$
|
84
|
||||
|
March 31,
2017
|
December 31,
2016
|
|||||||||||||||||||||||||||
|
Cost
|
Gross
Unrealized
Losses
|
Estimated
Fair
Value
|
Cost
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Estimated
Fair
Value
|
||||||||||||||||||||||
|
Cash and cash equivalents
|
$
|
3,978
|
$
|
-
|
$
|
3,978
|
$
|
2,786
|
$
|
-
|
$
|
-
|
$
|
2,786
|
||||||||||||||
|
U.S. Governmental agency obligations
|
27,981
|
(1,418
|
)
|
26,563
|
29,156
|
19
|
(1,551
|
)
|
27,624
|
|||||||||||||||||||
|
$
|
31,959
|
$
|
(1,418
|
)
|
$
|
30,541
|
$
|
31,942
|
$
|
19
|
$
|
(1,551
|
)
|
$
|
30,410
|
|||||||||||||
|
March 31,
2017
|
December 31,
2016
|
|||||||
|
Less than five years
|
$
|
9,113
|
$
|
9,113
|
||||
|
Six to ten years
|
15,896
|
16,141
|
||||||
|
Greater than ten years
|
2,972
|
3,902
|
||||||
|
Total U.S. Governmental agency obligations
|
$
|
27,981
|
$
|
29,156
|
||||
|
Deposits
|
||||||||
|
Sales
Year
|
March 31,
2017
|
December 31,
2016
|
||||||
|
1999
|
$
|
211
|
$
|
211
|
||||
|
2000
|
1,017
|
1,017
|
||||||
|
2001
|
1,673
|
1,673
|
||||||
|
2002
|
2,271
|
2,271
|
||||||
|
2003
|
4,249
|
4,249
|
||||||
|
2004
|
3,715
|
3,715
|
||||||
|
2005
|
4,552
|
4,552
|
||||||
|
2006
|
3,847
|
3,847
|
||||||
|
2007
|
4,167
|
4,167
|
||||||
|
2008
|
3,364
|
3,364
|
||||||
|
2009
|
1,626
|
1,626
|
||||||
|
2010
|
406
|
406
|
||||||
|
2011
|
193
|
193
|
||||||
|
2012
|
199
|
199
|
||||||
|
2013
|
173
|
173
|
||||||
|
2014
|
142
|
142
|
||||||
|
2015
|
101
|
100
|
||||||
|
2016
|
53
|
37
|
||||||
|
Total
|
$
|
31,959
|
$
|
31,942
|
||||
|
Purchase price:
|
||||
|
Total purchase price
|
$
|
27,000
|
||
|
Adjustments to purchase price:
|
||||
|
Working capital
|
(400
|
)
|
||
|
Fair value of holdback
|
(128
|
)
|
||
|
Adjusted purchase price
|
$
|
26,472
|
||
|
Assets acquired:
|
||||
|
Working capital
|
$
|
4,587
|
||
|
Property and equipment
|
7
|
|||
|
Other intangible assets
|
16,272
|
|||
|
Net assets acquired
|
$
|
20,866
|
||
|
Goodwill
|
$
|
5,606
|
||
|
March 31,
2017
|
December 31,
2016
|
|||||||
|
Raw materials and work in process
|
$
|
2,652
|
$
|
2,596
|
||||
|
Leaf tobacco
|
26,295
|
27,391
|
||||||
|
Finished goods - smokeless products
|
6,010
|
4,789
|
||||||
|
Finished goods - smoking products
|
17,248
|
18,384
|
||||||
|
Finished goods - electronic / vaporizer products
|
12,912
|
11,993
|
||||||
|
Other
|
1,157
|
1,232
|
||||||
|
66,274
|
66,385
|
|||||||
|
LIFO reserve
|
(5,388
|
)
|
(4,200
|
)
|
||||
|
$
|
60,886
|
$
|
62,185
|
|||||
|
March 31,
2017
|
December 31,
2016
|
|||||||
|
Land
|
$
|
22
|
$
|
22
|
||||
|
Building and improvements
|
1,899
|
1,899
|
||||||
|
Leasehold improvements
|
1,666
|
1,666
|
||||||
|
Machinery and equipment
|
10,898
|
10,532
|
||||||
|
Furniture and fixtures
|
3,411
|
3,409
|
||||||
|
17,896
|
17,528
|
|||||||
|
Accumulated depreciation
|
(10,292
|
)
|
(9,938
|
)
|
||||
|
$
|
7,604
|
$
|
7,590
|
|||||
|
March 31,
2017
|
December 31,
2016
|
|||||||
|
Accrued payroll and related items
|
$
|
1,494
|
$
|
5,331
|
||||
|
Customer returns and allowances
|
2,025
|
2,818
|
||||||
|
Other
|
6,842
|
7,187
|
||||||
|
$
|
10,361
|
$
|
15,336
|
|||||
|
March 31,
2017
|
December 31,
2016
|
|||||||
|
2017 First Lien First Out Term Loan
|
$
|
110,000
|
$
|
-
|
||||
|
2017 First Lien Second Out Term Loan
|
35,000
|
-
|
||||||
|
2017 Second Lien Term Loan
|
55,000
|
-
|
||||||
|
Note payable - VaporBeast
|
2,000
|
2,000
|
||||||
|
First Lien Term Loan
|
-
|
146,451
|
||||||
|
Second Lien Term Loan
|
-
|
59,128
|
||||||
|
Total Notes Payable and Long-Term Debt
|
202,000
|
207,579
|
||||||
|
Less deferred finance charges
|
(4,154
|
)
|
(4,388
|
)
|
||||
|
Less current maturities
|
(5,850
|
)
|
(1,650
|
)
|
||||
|
$
|
191,996
|
$
|
201,541
|
|||||
|
Pension Benefits
|
Postretirement Benefits
|
|||||||||||||||
|
Three months ended
|
Three months ended
|
|||||||||||||||
|
March 31,
2017
|
March 31,
2016
|
March 31,
2017
|
March 31,
2016
|
|||||||||||||
|
Service cost
|
$
|
26
|
$
|
26
|
$
|
-
|
$
|
-
|
||||||||
|
Interest cost
|
170
|
175
|
58
|
52
|
||||||||||||
|
Expected return on plan assets
|
(256
|
)
|
(259
|
)
|
-
|
-
|
||||||||||
|
Amortization of gains and losses
|
120
|
123
|
-
|
-
|
||||||||||||
|
Net periodic benefit cost
|
$
|
60
|
$
|
65
|
$
|
58
|
$
|
52
|
||||||||
|
Incentive
Shares
|
Weighted
Average
Exercise
Price
|
Weighted
Average
Grant Date
Fair Value
|
||||||||||
|
Outstanding, December 31, 2015
|
1,667,671
|
$
|
2.19
|
$
|
1.20
|
|||||||
|
Granted
|
53,996
|
9.26
|
2.37
|
|||||||||
|
Exercised
|
(73,135
|
)
|
2.31
|
1.27
|
||||||||
|
Forfeited
|
(10,770
|
)
|
3.83
|
2.17
|
||||||||
|
Outstanding, December 31, 2016
|
1,637,762
|
2.41
|
1.23
|
|||||||||
|
Granted
|
40,000
|
13.00
|
3.98
|
|||||||||
|
Exercised
|
(422,487
|
)
|
1.61
|
0.86
|
||||||||
|
Surrendered
|
(83,400
|
)
|
1.06
|
0.54
|
||||||||
|
Outstanding, March 31, 2017
|
1,171,875
|
$
|
3.16
|
$
|
1.51
|
|||||||
|
2016 Grant
|
2017 Grant
|
|||||||
|
Number of options
|
53,996
|
40,000
|
||||||
|
Number exercisable
|
26,998
|
-
|
||||||
|
Exercise price
|
$
|
9.26
|
$
|
13.00
|
||||
|
Remaining lives
|
9.3
|
9.9
|
||||||
|
Risk free interest rate
|
1.159
|
%
|
1.890
|
%
|
||||
|
Expected volatility
|
25.40
|
%
|
27.44
|
%
|
||||
|
Expected life
|
5.375
|
6.000
|
||||||
|
Dividend yield
|
-
|
-
|
||||||
|
Fair value
|
$
|
2.37
|
$
|
3.98
|
||||
|
Three Months Ended
|
||||||||||||||||||||||||
|
March 31,
2017
|
March 31,
2016
|
|||||||||||||||||||||||
|
Income
|
Shares
|
Per
Share
|
Income
|
Shares
|
Per
Share
|
|||||||||||||||||||
|
Net income
|
$
|
1,877
|
$
|
2,234
|
||||||||||||||||||||
|
Basic EPS:
|
||||||||||||||||||||||||
|
Weighted average
|
18,734,393
|
$
|
0.10
|
7,198,337
|
$
|
0.31
|
||||||||||||||||||
|
Diluted EPS:
|
||||||||||||||||||||||||
|
Effect of Dilutive securities:
|
||||||||||||||||||||||||
|
Stock options and warrants
|
898,960
|
1,156,322
|
||||||||||||||||||||||
|
19,633,353
|
$
|
0.10
|
8,354,659
|
$
|
0.27
|
|||||||||||||||||||
|
March 31,
2017
|
March 31,
2016
|
|||||||
|
Net Sales
|
||||||||
|
Smokeless products
|
$
|
20,248
|
$
|
18,339
|
||||
|
Smoking products
|
27,177
|
27,885
|
||||||
|
NewGen products
|
19,363
|
3,642
|
||||||
|
$
|
66,788
|
$
|
49,866
|
|||||
|
Operating Income
|
||||||||
|
Smokeless products
|
$
|
3,437
|
$
|
3,559
|
||||
|
Smoking products
|
6,554
|
7,540
|
||||||
|
NewGen products
|
912
|
116
|
||||||
|
Other (1)
|
(146
|
)
|
(306
|
)
|
||||
|
$
|
10,757
|
$
|
10,909
|
|||||
|
Interest expense
|
$
|
(4,933
|
)
|
$
|
(8,462
|
)
|
||
|
Investment income
|
114
|
|||||||
|
Loss on extinguishment of debt
|
(6,116
|
)
|
-
|
|||||
|
Income (loss) before income taxes
|
$
|
(178
|
)
|
$
|
2,447
|
|||
|
Capital Expenditures
|
||||||||
|
Smokeless products
|
$
|
366
|
$
|
329
|
||||
|
NewGen products
|
2
|
125
|
||||||
|
$
|
368
|
$
|
454
|
|||||
|
Depreciation and amortization
|
||||||||
|
Smokeless products
|
$
|
352
|
$
|
293
|
||||
|
NewGen products
|
177
|
-
|
||||||
|
$
|
529
|
$
|
293
|
|||||
|
March 31,
2017
|
December 31,
2016
|
|||||||
|
Assets
|
||||||||
|
Smokeless Products
|
$
|
85,748
|
$
|
85,559
|
||||
|
Smoking Products
|
149,158
|
150,498
|
||||||
|
NewGen Products
|
40,676
|
39,416
|
||||||
|
Other (1)
|
13,725
|
9,547
|
||||||
|
$
|
289,307
|
$
|
285,020
|
| (1) |
“Other” includes our assets that are not assigned to our three reportable segments, such as deferred taxes. All goodwill has been allocated to our reportable segments.
|
|
Three Months Ended
|
||||||||
|
March 31,
2017
|
March 31,
2016
|
|||||||
|
Domestic
|
$
|
64,371
|
$
|
46,974
|
||||
|
Foreign
|
2,417
|
2,892
|
||||||
|
Net Sales
|
$
|
66,788
|
$
|
49,866
|
||||
| · |
declining sales of tobacco products, and expected continuing decline of sales, in the tobacco industry overall;
|
| · |
our dependence on a small number of third-party suppliers and producers;
|
| · |
the possibility that we will be unable to identify or contract with new suppliers or producers in the event of a supply or product disruption;
|
| · |
the possibility that our licenses to use certain brands or trademarks will be terminated, challenged or restricted;
|
| · |
failure to maintain consumer brand recognition and loyalty of our customers;
|
| · |
substantial and increasing U.S. regulation;
|
| · |
regulation of our products by the FDA, which has broad regulatory powers;
|
| · |
uncertainty related to the regulation and taxation of our NewGen products;
|
| · |
possible significant increases in federal, state and local municipal tobacco-related taxes;
|
| · |
possible significant increases in tobacco-related taxes;
|
| · |
possible increasing international control and regulation;
|
| · |
our reliance on relationships with several large retailers and national chains for distribution of our products;
|
| · |
intense competition and our ability to compete effectively;
|
| · |
significant potential product liability litigation;
|
| · |
the scientific community’s lack of information regarding the long-term health effects of electronic cigarettes, vaporizer and e-liquid use;
|
| · |
our amount of indebtedness;
|
| · |
the terms of our credit facilities, which may restrict our current and future operations;
|
| · |
competition from illicit sources;
|
| · |
our reliance on information technology;
|
| · |
security and privacy breaches;
|
| · |
contamination of our tobacco supply or products;
|
| · |
infringement on our intellectual property;
|
| · |
third-party claims that we infringe on their intellectual property;
|
| · |
concentration of business with large customers;
|
| · |
failure to manage our growth;
|
| · |
failure to successfully integrate our acquisitions or otherwise be unable to benefit from pursuing acquisitions;
|
| · |
failure to achieve the expected benefits of the VaporBeast acquisition and to integrate VaporBeast’s operations with ours;
|
| · |
fluctuations in our results;
|
| · |
exchange rate fluctuations;
|
| · |
adverse U.S. and global economic conditions;
|
| · |
failure to comply with certain regulations;
|
| · |
departure of key management personnel or our inability to attract and retain talent;
|
| · |
decrease in value of our deferred tax assets;
|
| · |
imposition of significant tariffs on imports into the U.S.;
|
| · |
reduced disclosure requirements applicable to emerging growth companies may make our common stock less attractive to investors, potentially decreasing our stock price;
|
| · |
failure to maintain our status as an emerging growth company before the five-year maximum time period a company may retain such status;
|
| · |
our principal stockholders will be able to exert significant influence over matters submitted to our stockholders and may take certain actions to prevent takeovers;
|
| · |
our certificate of incorporation and bylaws, as well as Delaware law and certain regulations, could discourage or prohibit acquisition bids or merger proposals, which may adversely affect the market price of our common stock;
|
| · |
our certificate of incorporation limits the ownership of our common stock by individuals and entities that are Restricted Investors. These restrictions may affect the liquidity of our common stock and may result in Restricted Investors being required to sell or redeem their shares at a loss or relinquish their voting, dividend and distribution rights;
|
| · |
future sales of our common stock in the public market could reduce our stock price, and any additional capital raised by us through the sale of equity or convertible securities may dilute your ownership in us; and
|
| · |
we may issue preferred stock whose terms could adversely affect the voting power or value of our common stock.
|
| • |
Our ability to further penetrate markets with our existing products;
|
| • |
Our ability to introduce new products and product lines that complement our core business;
|
| • |
Decreasing interest in tobacco products among consumers;
|
| • |
Price sensitivity in our end-markets;
|
| • |
Marketing and promotional initiatives, which cause variability in our results;
|
| • |
General economic conditions, including consumer access to disposable income;
|
| • |
Cost and increasing regulation of promotional and advertising activities;
|
| • |
Cost of complying with regulation, including newly passed “deeming regulations”;
|
| • |
Counterfeit and other illegal products in our end-markets;
|
| • |
Currency fluctuations;
|
| • |
Our ability to identify attractive acquisition opportunities in OTP; and
|
| • |
Our ability to integrate acquisitions.
|
|
Three Months Ended March 31,
|
||||||||||||
|
2017
|
2016
|
% Change
|
||||||||||
|
Consolidated Results of Operations Data:
|
||||||||||||
|
Net sales
|
||||||||||||
|
Smokeless products
|
$
|
20,248
|
$
|
18,339
|
10.4
|
%
|
||||||
|
Smoking products
|
27,177
|
27,885
|
-2.5
|
%
|
||||||||
|
NewGen products
|
19,363
|
3,642
|
431.7
|
%
|
||||||||
|
Total net sales
|
66,788
|
49,866
|
33.9
|
%
|
||||||||
|
Cost of sales
|
39,122
|
25,219
|
55.1
|
%
|
||||||||
|
Gross profit
|
||||||||||||
|
Smokeless products
|
9,254
|
9,210
|
0.5
|
%
|
||||||||
|
Smoking products
|
13,700
|
14,308
|
-4.2
|
%
|
||||||||
|
NewGen products
|
4,712
|
1,129
|
317.4
|
%
|
||||||||
|
Total gross profit
|
27,666
|
24,647
|
12.2
|
%
|
||||||||
|
Selling, general and administrative expenses
|
16,909
|
13,738
|
23.1
|
%
|
||||||||
|
Operating income
|
10,757
|
10,909
|
-1.4
|
%
|
||||||||
|
Interest expense
|
4,933
|
8,462
|
-41.7
|
%
|
||||||||
|
Investment income
|
(114
|
)
|
-
|
100.0
|
%
|
|||||||
|
Loss on extinguishment of debt
|
6,116
|
-
|
100.0
|
%
|
||||||||
|
Income (loss) before income taxes
|
(178
|
)
|
2,447
|
-107.3
|
%
|
|||||||
|
Income tax expense (benefit)
|
(2,055
|
)
|
213
|
-1064.8
|
%
|
|||||||
|
Net income
|
$
|
1,877
|
$
|
2,234
|
-16.0
|
%
|
||||||
|
Three Months Ended
|
||||||||
|
March 31,
2017
|
March 31,
2016
|
|||||||
|
Net income
|
$
|
1,877
|
$
|
2,234
|
||||
|
Add:
|
||||||||
|
Interest expense
|
4,933
|
8,462
|
||||||
|
Loss on extinguishment of debt
|
6,116
|
-
|
||||||
|
Income tax expense (benefit)
|
(2,055
|
)
|
213
|
|||||
|
Depreciation expense
|
354
|
293
|
||||||
|
Amortization expense
|
175
|
-
|
||||||
|
EBITDA
|
$
|
11,400
|
$
|
11,202
|
||||
|
Components of Adjusted EBITDA
|
||||||||
|
LIFO adjustment (a)
|
1,189
|
309
|
||||||
|
Pension/postretirement expense (b)
|
118
|
117
|
||||||
|
Stock options, restricted stock and incentives expense (c)
|
45
|
22
|
||||||
|
Foreign exchange hedging (d)
|
(69
|
)
|
(21
|
)
|
||||
|
Strategic initiatives (e)
|
327
|
432
|
||||||
|
Launch costs (f)
|
628
|
392
|
||||||
|
Adjusted EBITDA
|
$
|
13,638
|
$
|
12,453
|
||||
| (a) |
Represents expense related to an inventory valuation allowance for last-in, first-out ("LIFO") reporting.
|
| (b) |
Represents our non-cash Pension/Postretirement expense.
|
| (c) |
Represents non-cash stock options, restricted stock and incentives expense.
|
| (d) |
Represents non-cash gain and loss stemming from our foreign exchange hedging activities.
|
| (e) |
Represents the fees incurred for the study of strategic initiatives.
|
| (f) |
Represents non-recurring product launch costs of our new product lines.
|
|
March 31,
2017
|
December 31,
2016
|
|||||||
|
Current Assets
|
$
|
80,161
|
$
|
78,856
|
||||
|
Current Liabilities
|
53,719
|
41,567
|
||||||
|
Working Capital
|
$
|
26,442
|
$
|
37,289
|
||||
|
Three Months Ended
|
||||||||
|
March 31,
2017
|
March 31,
2016
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income
|
$
|
1,877
|
$
|
2,234
|
||||
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
|
||||||||
|
Loss on extinguishment of debt
|
6,116
|
-
|
||||||
|
Depreciation expense
|
354
|
293
|
||||||
|
Amortization of deferred financing costs
|
294
|
362
|
||||||
|
Amortization of original issue discount
|
66
|
259
|
||||||
|
Amortization of other intangible assets
|
175
|
-
|
||||||
|
Interest incurred but not paid on PIK toggle notes
|
-
|
2,254
|
||||||
|
Deferred income taxes
|
(2,564
|
)
|
41
|
|||||
|
Stock-based compensation expense
|
45
|
22
|
||||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Accounts receivable
|
(1,801
|
)
|
1,291
|
|||||
|
Inventories
|
1,299
|
(3,637
|
)
|
|||||
|
Other current assets
|
(1,420
|
)
|
1,455
|
|||||
|
Other assets
|
26
|
416
|
||||||
|
Accounts payable
|
(1,597
|
)
|
724
|
|||||
|
Accrued pension liabilities
|
60
|
64
|
||||||
|
Accrued postretirement liabilities
|
32
|
(28
|
)
|
|||||
|
Accrued expenses and other
|
(5,302
|
)
|
(4,773
|
)
|
||||
|
Net cash provided by (used in) operating activities
|
$
|
(2,340
|
)
|
$
|
977
|
|||
|
Three Months Ended
|
||||||||
|
March 31,
2017
|
March 31,
2016
|
|||||||
|
Cash flows from investing activities:
|
||||||||
|
Capital expenditures
|
$
|
(368
|
)
|
$
|
(454
|
)
|
||
|
Net cash used in investing activities
|
$
|
(368
|
)
|
$
|
(454
|
)
|
||
|
Three Months Ended
|
||||||||
|
March 31,
2017
|
March 31,
2016
|
|||||||
|
Cash flows from financing activities:
|
||||||||
|
Proceeds from 2017 revolving credit facility
|
$
|
29,550
|
$
|
-
|
||||
|
Proceeds from 2017 first lien term loans
|
145,000
|
-
|
||||||
|
Proceeds from 2017 second lien term loan
|
55,000
|
-
|
||||||
|
Payments of financing costs
|
(4,792
|
)
|
-
|
|||||
|
Proceeds from (payments of) old revolving credit facility
|
(15,034
|
)
|
1,000
|
|||||
|
Payments of first lien term loan
|
(147,312
|
)
|
-
|
|||||
|
Payments of second lien term loan
|
(60,000
|
)
|
-
|
|||||
|
Prepaid equity issuance costs
|
-
|
(268
|
)
|
|||||
|
Exercise of options
|
679
|
-
|
||||||
|
Surrender of options
|
(1,000
|
)
|
(3,150
|
)
|
||||
|
Net cash provided by (used in) financing activities
|
$
|
2,091
|
$
|
(2,418
|
)
|
|||
|
March 31,
2017
|
December 31,
2016
|
|||||||
|
2017 Revolving Credit Facility
|
$
|
29,550
|
$
|
-
|
||||
|
2017 First Lien First Out Term Loan
|
110,000
|
-
|
||||||
|
2017 First Lien Second Out Term Loan
|
35,000
|
-
|
||||||
|
2017 Second Lien Term Loan
|
55,000
|
-
|
||||||
|
Notes payable - VaporBeast
|
2,000
|
2,000
|
||||||
|
Revolving Credit Facility
|
-
|
15,034
|
||||||
|
First Lien Term Loan
|
-
|
146,451
|
||||||
|
Second Lien Term Loan
|
-
|
59,128
|
||||||
|
231,550
|
222,613
|
|||||||
|
Less deferred financing charges
|
(4,154
|
)
|
(4,388
|
)
|
||||
|
Less revolving credit facility
|
(29,550
|
)
|
(15,034
|
)
|
||||
|
Less current maturities of long-term debt
|
(5,850
|
)
|
(1,650
|
)
|
||||
|
$
|
191,996
|
$
|
201,541
|
|||||
|
Payments due by period as of March 31, 2017
|
||||||||||||||||||||
|
Long-Term Debt Obligations
|
Total
|
Less than
1 year
|
1-3 years
|
4-5 years
|
More than
5 years
|
|||||||||||||||
|
Long-term debt obligations, including interest
|
$
|
291,695
|
$
|
49,520
|
$
|
38,922
|
$
|
112,568
|
$
|
90,685
|
||||||||||
|
Payments due by period as of December 31, 2016
|
||||||||||||||||||||
|
Long-Term Debt Obligations
|
Total
|
Less than
1 year
|
1-3 years
|
4-5 years
|
More than
5 years
|
|||||||||||||||
|
Long-term debt obligations, including interest
|
$
|
288,837
|
$
|
39,380
|
$
|
44,477
|
$
|
204,980
|
$
|
-
|
||||||||||
|
PART II
|
OTHER INFORMATION
|
|
TURNING POINT BRANDS, INC.
|
|||
|
By: /s/ Lawrence S. Wexler
|
|||
|
Name: Lawrence S. Wexler
|
|||
|
Title: Chief Executive Officer
|
|||
|
/s/ Mark A. Stegeman
|
|||
|
Name: Mark A. Stegeman
|
|||
|
Title: Chief Financial and Accounting Officer
|
|||
|
Dated: May 11, 2017
|
|||
|
Description
|
|
|
10.1
|
Amendment No. 3 to the 2006 Equity Incentive Plan of North Atlantic Holding Company, Inc. (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No. 001-37763) filed on February 9, 2017).
†
|
|
10.2
|
Form of Cash-Out Agreement under the 2006 Equity Incentive Plan of North Atlantic Holding Company, Inc. (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K (File No. 001-37763) filed on February 9, 2017).
†
|
|
Form of Performance-Based Restricted Stock Unit Award Agreement under the
Turning Point Brands, Inc. 2015 Equity Incentive Plan
.*
†
|
|
|
10.4
|
First Lien Credit Agreement, dated as of February 17, 2017, by and among Turning Point Brands, Inc. and North Atlantic Trading Company, Inc., as the Borrowers, Fifth Third Bank, as administrative agent, and the lenders party thereto (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No. 001-37763) filed on February 21, 2017).
|
|
10.5
|
Second Lien Credit Agreement, dated as of February 17, 2017, by and among Turning Point Brands, Inc. and North Atlantic Trading Company, Inc., as the Borrowers, Prospect Capital Corporation, as administrative agent, and the lenders party thereto (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K (File No. 001-37763) filed on February 21, 2017).
|
|
10.6
|
First Lien Guaranty and Security Agreement, dated as of February 17, 2017, by and among Turning Point Brands, Inc. and its subsidiaries, as the Grantors, Fifth Third Bank, as administrative agent, and the lenders party thereto (incorporated by reference to Exhibit 10.3 to the Registrant’s Current Report on Form 8-K (File No. 001-37763) filed on February 21, 2017).
|
|
10.7
|
Second Lien Guaranty and Security Agreement, dated as of February 17, 2017, by and among Turning Point Brands, Inc. and its subsidiaries, as the Grantors, Prospect Capital Corporation, as administrative agent, and the lenders party thereto (incorporated by reference to Exhibit 10.4 to the Registrant’s Current Report on Form 8-K (File No. 001-37763) filed on February 21, 2017).
|
|
10.8
|
Second Lien Intercreditor Agreement, dated as of February 17, 2017, by and among Turning Point Brands, Inc., North Atlantic Trading Company, Inc. and the other grantors party thereto, Fifth Third Bank, as first lien collateral agent, and Prospect Capital Corporation, as second lien collateral agent (incorporated by reference to Exhibit 10.5 to the Registrant’s Current Report on Form 8-K (File No. 001-37763) filed on February 21, 2017).
|
|
Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
|
|
|
Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
|
|
|
Certifications of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
|
|
| 101 |
XBRL(eXtensible Business Reporting language). The Following materials from Turning Point Brands, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2017, filed on May 11, 2017, formatted in XBRL: (i) consolidated balance sheets, (ii) consolidated statements of income, (iii) consolidated statements of comprehensive income, (iv) consolidated statements of cash flows, and (v) the notes to consolidated financial statements.*
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|